Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Clinical Interventions in Aging|October 11, 2014
Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric AssessmentPhilippe Caillet, Marie Laurent, Sylvie Bastuji-Garin, et al.
Marine Drugs|October 21, 2009
Phase II study of biweekly plitidepsin as second-line therapy for advanced or metastatic transitional cell carcinoma of the urotheliumHerlinde Dumez, Enrique Gallardo, Stephane Culine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA studyPhilippe Caillet, Florence Canoui-Poitrine, Johanna Vouriot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2006
[What is the objective of second-line chemotherapy after failure of first-line chemotherapy in hormone-resistant metastatic prostate?]Mounira El Demery, Damien Pouessel, Christophe Avancès, et al.
Clinical Nuclear Medicine|August 8, 2015
18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate CancerLaurent Quero, Laetitia Vercellino, Eric de Kerviler, et al.
European Urology|February 27, 2023
Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor TrialsAna Cavillon, Damien Pouessel, Nadine Houédé, et al.
Bulletin Du Cancer|October 9, 2014
[Alternative prescription schedules of sunitinib in metastatic kidney cancer: from the underground to the light?]Antoine Thiery-Vuillemin, Guillaume Mouillet, Damien Pouessel, et al.
European Urology|August 19, 2008
Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancerAntoine Italiano, Cécile Ortholan, Stéphane Oudard, et al.
Bulletin Du Cancer|June 23, 2022
[Metastatic renal cell carcinoma: Management of toxicities of combinations]Florence Joly, Jean-Marie Michot, Louis Marie Dourthe, et al.
Journal of Geriatric Oncology|February 4, 2014
Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: the ELCAPA-02 studyEvelyne Liuu, Florence Canouï-Poitrine, Christophe Tournigand, et al.
Pageof 12